Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...

Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

Wake up and go to sleep The irony of these two narcolepsy drugs that work to normalise the sleep-wake cycle is that they have to be taken twice per night. Patients have the first dose before they ...

Avadel Pharmaceuticals expects its narcolepsy treatment Lumryz to drive strong revenue growth in the fourth quarter and into 2025, preliminary earnings show. The Dublin-based company anticipates ...

Sales of its narcolepsy drug, LUMRYZ rose by 150% YoY. AVDL expects net product revenue for 2025 in the range of $240 million to $260 million. Get the Real Story Behind Every Major Earnings Report ...

A leading sleep expert highlighted the drug's transformative potential across narcolepsy subtypes and idiopathic hypersomnia (IH), suggesting it could significantly improve wakefulness compared to ...

And even though Jazz Pharmaceuticals (JAZZ) is a formidable competitor with its low sodium, twice nightly narcolepsy drug Xywav, all these problems sound like Lumryz problems, and overall ...

Alkermes wants to augment its pipeline with M&A or licensing deals in serious mental illnesses and substance abuse. “I think anyone who's developing a drug in these spaces, they are probably better ...

DUBLIN - Avadel Pharmaceuticals plc (NASDAQ: NASDAQ:AVDL), a company specializing in the development of transformative medicines with a market capitalization of $1.05 billion, has announced ...

A narcolepsy service dog is a long term commitment. But having one can help you live a safer life by alerting you before a narcolepsy episode. They can also help with other daily tasks and provide ...

“People with narcolepsy, the drugs they’ve been using to treat their condition have basically been blunt instruments,” Pops said of the current array of stimulants and sedatives that treat ...